Sarepta Therapeutics (SRPT) Will Post Q3 Results on Nov. 6th; Street Sees Wider Loss Oct 31, 2014 03:36PM

Sarepta Therapeutics (NASDAQ: SRPT) will report third quarter 2014 financial results before the NASDAQ Global Market opens on Thursday, November 6, 2014. Subsequently, at 8:00 a.m. Eastern Time, Chris Garabedian, Sarepta’s president and chief executive officer, and Sandy Mahatme, Sarepta’s chief financial officer, will host a conference call to discuss third quarter financial results and to provide a corporate update.

*** The Street is currently looking for Sarepta to post Q3 loss of $0.96 per share with revenue of $3.1 million, from a loss of $0.63 per share and revs of $4.2 million reported in the same period last year.

The conference call may be accessed by dialing 800-708-4539 for domestic callers and 847-619-6396 for international callers. The passcode for the call is 38322454. Please specify to the operator that you would like to join the "Sarepta Third Quarter 2014 Earnings Call." The conference call will be webcast live under the investor relations section of Sarepta's website at and will be archived there following the call for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Starbucks (SBUX) CEO Schultz: Apple Pay is 'Great' for Starbucks - Conf. Call Oct 31, 2014 09:54AM

Starbucks Coffee (NASDAQ: SBUX) CEO Howard Schultz said Apple Pay is 'Great' for Starbucks, according to the company's quarterly call.

American Realty Capital Properties (ARCP) to Hold Conference Call Today Oct 29, 2014 02:57PM

American Realty Capital Properties, Inc. (NASDAQ: ARCP) ("ARCP") announced that it will host an investor conference call at 3 p.m. ET (12 p.m. PT) on Wednesday, October 29 to discuss the company's earlier press release and 8-K filing.

Live Conference Call Details:

Wednesday, October 29, 2014 | 3 p.m. ET/12 p.m. PTDomestic Dial-In Number: 1-888-317-6003International Dial-In Number: 1-412-317-6061Canada Dial-In Number: 1-866-284-3684Conference ID: 3415920Participants should dial in 10-15 minutes early.

Call Replay Details:

Domestic Dial-In Number: 1-877-344-7529International Dial-In Number: 1-412-317-0088Canada Dial-In Number: 1-855-669-9658Conference ID: 10055521Date Available: October 29, 2014 (approximately one hour after the end of the conference call)

Tekmira Pharma (TKMR) Will Report Q3 Results Nov. 6th; Street Sees Wider Sequential Loss Oct 24, 2014 06:28AM

Tekmira Pharma (NASDAQ: TKMR) announced that it will hold a conference call and webcast on Thursday, November 6, 2014 at 2 p.m. Pacific Time (5 p.m. Eastern Time) to provide a corporate update and report financial results for the third quarter ended Sept 30, 2014.

*** Consensus estimates are looking for Tekmira to report Q3 loss of $0.31 per share on revenue of $3.71 million, from a loss of $0.28 per share with revenue of just $1.8 million posted in Q214.

Conference Call and Webcast Information

A live webcast of the call can be accessed through the Investor section of Tekmira's website at Or, alternatively, to access the conference call, please dial 914-495-8556 or 1-866-393-1607.

An archived webcast will be available on the Tekmira website approximately two hours after the event. Alternatively, you may access a replay of the conference call by calling 404-537-3406 or 1-855-859-2056 and referencing conference ID 7467109.

Biogen Idec (BIIB) Says Tecfidera Patient Who Died had Low White Blood Cell Counts Oct 22, 2014 11:52AM

Biogen Idec Inc. (BIIB) is seeing some unnecessary weakness Wednesday following Q3 results and the company's conference call.

Earlier, the WSJ cited the company as saying it confirmed a case of a rare brain infection in a patient who took Tecfidera and recently died from complications of pneumonia.

However, Biogen clarified that what it said was the patient taking Tecfidera who died had low white blood cell counts.

Biogen reported Q3 EPS of $3.80, $0.31 better than the analyst estimate of $3.49. Revenue for the quarter came in at $2.5 billion versus the consensus estimate of $2.48 billion. Tecfidera revenues were $787 million, consisting of $638 million in U.S. sales and $149 million in sales outside the U.S.

More Conference Calls

View Older Stories

Oct 21, 2014 06:09AM Tesla (TSLA) Will Report Q3 Results on Nov. 5th; Street Sees Revenue Doubling
Oct 13, 2014 05:08PM Horizon Pharma (HZNP) Sees Peak ACTIMMUNE Sales of ~$500M
Oct 13, 2014 04:53PM Exactech, Inc. (EXAC) Schedules Q3 Conf. Call; Sees Net Income Below Prior Guidance
Oct 13, 2014 03:31PM American Airlines Group (AAL) Will Release Q3 Results Oct. 23rd; Street Sees Sequential EPS Growth
Oct 8, 2014 04:39PM InvenSense (INVN) to Report Q2 Results Oct. 28th; Street Expects 24% EPS Drop
Oct 2, 2014 04:08PM J.C. Penney (JCP) Plans Analyst Meeting for Oct. 8th
Sep 29, 2014 07:10AM OncoMed Pharma (OMED) Issues Encouraging Update on ALPINE, PINNACLE Phase 1b Trials
Sep 29, 2014 06:08AM NiSource (NI) Will Separate into Two, Publicly-Traded Companies
Sep 26, 2014 08:05AM Genomic Health (GHDX) to Present Results from Second Oncotype DX Study at CTRC-AACR
Sep 24, 2014 07:35AM Newell Rubbermaid (NWL) Affirms FY14 Outlook; Guides FY15 into Analyst Day
Sep 23, 2014 04:06PM Lipocine (LPCN) to Host Conference Call to Discuss LPCN 1021 Top-Line Results
Sep 15, 2014 04:35PM GT Advanced Technologies (GTAT) Plans to Webcast Late-Sept. Business Update
Sep 10, 2014 02:41PM Avanir Pharmaceuticals (AVNR) Trades Higher Following Morgan Stanley Conference
Sep 10, 2014 02:32PM Synthesis Energy Systems (SYMX) Active Ahead of Q4 Report
Sep 5, 2014 12:19PM Keryx Biopharma (KERX) CEO: No Decision on NCE Status
Sep 2, 2014 09:51AM ASML Holdings (ASML) Shares Active; Execs Presenting at Citi Global Tech Conference
Sep 2, 2014 07:04AM BioCryst Pharma (BCRX) to Present Peramivir IV Data at ICAAC
Aug 28, 2014 08:09AM lululemon athletica (LULU) to Report Q2 Results Sept. 11th; Street Sees 26% Lower EPS
Aug 27, 2014 02:32PM Traders Get Cautious into Abercrombie & Fitch (ANF) Ahead of Q2 Report
Aug 26, 2014 09:38AM ZS Pharma (ZSPH) Gains Early; Plans Presentation of ZS-9 Phase 3 Data as Hyperkalemia Treatment
Aug 25, 2014 03:09PM Gyrodyne Co of America (GYRO) Further Postpones Special Shareholders Meeting
Aug 18, 2014 08:33AM Fabrinet (FN) Announces Investigation Following Discovery of Accounting Errors; Postpones FY14 Report, Conf. Call
Aug 18, 2014 07:57AM StealthGas (GASS) Prelim. Q2 Results Miss Expectations
Aug 14, 2014 04:46PM CorMedix's (CRMD) Neutrolin Phase III Protocol Accepted by U.S. FDA
Aug 14, 2014 02:33PM J.C. Penney (JCP) Ticks Higher into Q2 Report; Investors Hoping for Push Above Key Level
Aug 6, 2014 03:52PM Novavax, Inc. (NVAX) Trades Strong into Q2 Report
Aug 6, 2014 10:41AM Time Warner (TWX) CEO Not Commenting on Dropped Twenty-First Century Fox (FOXA) Bid
Aug 4, 2014 08:17AM Coach (COH) on the Rise Following Michael Kors Q1 Results
Jul 18, 2014 11:15AM Pershing Square Updates Information on Herbalife (HLF) Nutrition Clubs Presentation
Jul 18, 2014 10:07AM Tesla Motors (TSLA) Will Report Q2 Results on July 31st; Street Sees Revenue Doubling
Jul 17, 2014 04:28PM Rogers Corp. (ROG) Revises Q2 Outlook; EPS Comes in Below Expectations
Jul 16, 2014 07:40AM ARIAD Pharma (ARIA) Will Report Q2 Results Aug. 6th; Street Sees Narrower Loss
Jul 9, 2014 04:21PM Lumber Liquidators (LL) Prelim. Q2 Results Miss Expectations; FY14 Outlook Cut
Jul 9, 2014 02:22PM Lumber Liquidators (LL) Will Release Q2 Update Today; Street Sees 23% EPS Growth
Jul 9, 2014 06:26AM Microsoft (MSFT) Will Report Q4 Results on July 22nd; Street Sees Lower EPS
Jul 7, 2014 02:15PM Google (GOOGL) to Report Q2 Results on July 17th; Street sees 10.6% Revenue Growth
Jul 1, 2014 05:15PM WPCS INTL (WPCS) Adjourns Special Meeting due to Lack of Requisite Quorum
Jul 1, 2014 04:08PM Facebook (FB) Will Report Q2 Results on July 23rd; Street Sees 68% EPS Growth
Jun 30, 2014 04:23PM Herbalife (HLF) Will Report Q2 Results on July 28th; Street sees 11% EPS Growth
Jun 30, 2014 09:24AM Universal Truckload Services (UACL) Updates on Q2 Outlook; Approves 800K Stock Buyback
Jun 26, 2014 08:45AM Neonode (NEON) Updates on Conference Call Issues, Discussion
Jun 25, 2014 08:05AM McKesson Corp. (MCK) Reaffims FY15 Outlook
Jun 24, 2014 03:43PM Monsanto (MON) Lower into Q3 Report
Jun 24, 2014 06:39AM Synergy Resources (SYRG) Issues Update on FY14 Drilling Program
Jun 23, 2014 07:38AM Shire plc (SHPG) Sees Product Sales Doubling to $10B by 2020
Jun 19, 2014 11:31AM BlackBerry (BBRY) CEO Chen: Odds of Survival at About 80%
Jun 18, 2014 02:19PM (AMZN) Announces New 'Firefly' Feature; Search, Buy Items via Scanning
Jun 17, 2014 09:14AM SolarCity (SCTY) to Acquire Silevo in ~$350M All-Stock Deal
Jun 17, 2014 09:14AM SolarCity (SCTY) to Acquire Silevo in ~$350M All-Stock Deal
Jun 17, 2014 08:03AM Merrimack Pharmaceuticals (MACK) Will Make Oral Presentation on Phase 3 NAPOLI-1 Data
View Older Stories